LNA Santé S.A.
LNA.PA · PAR
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.18 | -0.23 | 0.63 | -1.29 |
| FCF Yield | 7.84% | 11.58% | 20.94% | 27.68% |
| EV / EBITDA | 14.56 | 17.48 | 23.71 | 23.82 |
| Quality | ||||
| ROIC | 1.35% | 4.11% | 1.25% | 1.57% |
| Gross Margin | 14.13% | 21.31% | 33.26% | 31.88% |
| Cash Conversion Ratio | 2.43 | 3.95 | 4.66 | 5.48 |
| Growth | ||||
| Revenue 3-Year CAGR | 11.13% | 11.87% | 11.27% | 11.14% |
| Free Cash Flow Growth | -36.08% | -39.26% | -7.53% | 227.33% |
| Safety | ||||
| Net Debt / EBITDA | 11.10 | 13.25 | 18.06 | 19.01 |
| Interest Coverage | 1.80 | 5.61 | 1.65 | 2.18 |
| Efficiency | ||||
| Inventory Turnover | 1.97 | 1.62 | 1.60 | 1.71 |
| Cash Conversion Cycle | 51.49 | 48.61 | 55.21 | 43.14 |